Skip to main content
. 2019 Dec;8(6):574–582. doi: 10.21037/tau.2019.10.15

Table 4. General characteristics of the patients in group 1 and group 2.

Group 1 2 P value
N 55 80
Age 33.91±11.78 34.01±9.96 0.231
Systolic (mmHg) 131.93±16.61 130.94±12.51 0.749
Diastolic (mmHg) 81.72±16.72 84.04±11.89 0.445
Blood glucose (mmol/L) 4.93±0.89 4.79±1.02 0.411
TC (mmol/L) 4.21±0.98 4.08±1.02 0.484
TG (mmol/L) 1.25±0.64 1.22±0.75 0.831
HDL (mmol/L) 1.12±0.24 1.16±0.30 0.549
LDL (mmol/L) 3.23±5.07 2.47±0.93 0.212
E (pmol/mL) 55.49±27.52 57.40±25.35 <0.05
FSH (mlU/mL) 6.60±5.68 4.78±3.15 <0.05
LH (mlU/mL) 4.81±2.99 5.42±7.54 0.571
PRL (nmol/L) 15.34±6.06 13.81±6.97 <0.05
T (nmol/L) 4.52±1.35 4.62±1.63 0.721
P (nmol/L) 0.85±0.48 1.04±0.57 0.054
Base 60 (min) 2.54±2.75 40.72±41.65 <0.01

Group 1, effective erection time ≤10 min; group 2, effective erection time >10 min. TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein; E, estradiol; FSH, follicle stimulating hormone; LH, luteinizing hormone; PRL, prolactin hormone; T, testosterone; P, progesterone; base 60, the time penile base rigidity greater than 60%.